Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliografía
[1]
Guidelines on Diagnosis and Management of Acute Pulmonary Embolism..
Task Force on Pulmonary Embolism, European Society of Cardiology..
Eur Heart J, (2000), 21 pp. 1301-36
[2]
White RH..
The epidemiology of venous thromboembolism..
Circulation, (2003), 107 pp. I4-8
[3]
Wicki J, Perrier A, Perneger T, Bounameaux H, Junos AF..
Predicting adverse outcome in patients with acute pulmonary embolism: a risk score..
Thromb Haemost, (2000), 84 pp. 548-52
[4]
Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ..
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study..
Arch Intern Med, (2000), 160 pp. 809-15
[5]
Wicki J, Perneger TV, Junod AF, Bounameaux H, Perrier A..
Assessing clinical probability of pulmonary embolism in the emergency ward..
Arch Intern Med, (2001), 161 pp. 92-7
[6]
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism..
Thorax, (2003), 58 pp. 470-83
[7]
Fancher TL, White RH, Kravitz RL..
Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review..
BMJ, (2004), 329 pp. 821-8
[8]
Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, et al..
D-dimer testing to determine the duration of anticoagulation therapy..
N Engl J Med, (2006), 355 pp. 1780-9
[9]
The PIOPED Investigators..
Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED)..
JAMA, (1990), 263 pp. 2753-9
[10]
Goldhaber SZ..
Multislice computed tomography for pulmonary embolism a technological marvel..
N Engl J Med, (2005), 352 pp. 1812-4
[11]
Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales Ch.A, Hull RD et al..
Multidetector computed tomography for acute pulmonary embolism..
N Engl J Med, (2006), 354 pp. 2317-27
[12]
Perrier A, Bounameaux H..
Accuracy or outcome in suspected pulmonary embolism..
N Engl J Med, (2006), 354 pp. 2383-5
[13]
Daniel KR, Jackson RE, Kline JA..
Utility of lower extremity venous ultrasound scanning in the diagnosis and exclusion of pulmonary embolism in outpatients..
Ann Emerg Med, (2000), 35 pp. 547-54
[14]
Maldjian PD, Chew FS..
Imaging of pulmonary embolism: self-assessment module..
AJR Am J Roentgenol, (2006), 186 pp. S215-8
[15]
Janata K, Holzer M, Laggner A, Mullner M..
Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study..
BMJ, (2003), 326 pp. 312-3
[16]
Kucher N, Goldhaber SZ..
Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism..
Circulation, (2003), 108 pp. 2191-4
[17]
Fedullo PF, Tapson VF..
The evaluation of suspected pulmonary embolism..
N Engl J Med, (2003), 349 pp. 1247-56
[18]
Perrier A, Roy PM, Sánchez O, Le Gal G, Meyer G, Gourdier AL, et al..
Multidetector-row computed tomography in suspected pulmonary embolism..
N Engl J Med, (2005), 352 pp. 1760-8
[19]
Perrier A, Roy PM, Aujesky D, Chagnon I, Howarth N, Gourdier AL, et al..
Diagnosing pulmonary embolism in outpatients with clinical assessment, D-Dimer measurement, venous ultrasound and helical computed tomography: a multicenter management study..
Am J Med, (2004), 116 pp. 291-9
[20]
Hirsh J, Raschke R..
Heparin and low-molecular-weight heparin: The Seventh ACCP Conference on Antithrombotic and Trombolytic Therapy..
Chest, (2004), 126 pp. 188-203
[21]
Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskobb GE..
Antithrombotic therapy for venous thromboembolic disease: The Seventh ACCP Conference on Antithrombotic and Trombolytic Therapy..
Chest, (2004), 126 pp. 401-28
[22]
Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S..
Hemorrhagic complications of anticoagulant treatment: The Seventh ACCP Conference on Antithrombotic and Trombolytic Therapy..
Chest, (2004), 126 pp. 287-310
[23]
Warkentin TE, Greinacher A..
Heparin-induced thrombocytopenia: recognition, treatment and prevention: The Seventh ACCP Conference on Antithrombotic and Trombolytic Therapy..
Chest, (2004), 126 pp. 311-37
[24]
Van Gogh Investigators..
Idraparinux versus standard therapy for venous thromboembolic disease..
N Engl J Med, (2007), 357 pp. 1094-104
[25]
Weitz JI, Hirsh J, Samana MM..
New anticoagulant drugs: The Seventh ACCP Conference on Antithrombotic and Trombolytic Therapy..
Chest, (2004), 126 pp. 265-86
[26]
Robinson DM, Wellington K..
Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism..
Am J Cardiovasc Drugs, (2005), 5 pp. 335-46
[27]
Kucher N, Rossi E, De Rosa M, Goldhaber SZ..
Massive pulmonary embolism..
Circulation, (2006), 113 pp. 577-82
[28]
Management of massive pulmonary embolism. Circulation. 2005:112;e28-e32.
[29]
Ruiz-Bailén M, Aguayo-de-Hoyos E, Serrano-Corcoles MC, Díaz-Castellanos MA, Fierro-Rosón JL, Ramos-Cuadra JA, et al..
Thrombolysis with recombinant tissue plasminogen activator during cardiopulmonary resuscitation in fulminant pulmonary embolism. A case series..
Resucitation, (2001), 51 pp. 97-101
[30]
Konstantinides S, Geibel A, Heusel G..
Heinrich F, Kasper W; Management strategies and prognosis of pulmonary embolism-3 trial investigators. Heparin plus alteplase compared with heparine alone in patients with submassive pulmonary embolism..
N Engl J Med, (2002), 347 pp. 1143-50
[31]
Hill J, Treasure T..
Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients having surgery: summary of NICE guidance..
BMJ, (2007), 334 pp. 1053-5
[32]
Francis CW..
Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients..
N Engl J Med, (2007), 356 pp. 1438-44
